The mission of the Genome Biology and Genetic Diseases Program is to harness advanced genomics and molecular technologies to deepen our understanding of genomes and improve human health, drive biotechnological innovation, and train the next generation of genomic biomedical researchers.
Researchers are focussed on harnessing and re-engineering genes to improve your quality of life by:
The key priority of the GB&GD team is to decode the genetic and epigenetic drivers of disease and ageing, harness artificial intelligence to develop personalised diagnostic tools, and continue to explore treatments and preventive strategies for neurological and neuromuscular conditions.
The Genome Biology & Genetic Diseases Program is led by Professor Ryan Lister.
All donations of $2 and over are tax deductible in Australia.
Perkins is registered with the Australian Taxation Office as a Deductible Gift Recipient (DGR): Charitable Fundraising Authority No DGR CC20761
The Harry Perkins Institute of Medical Research recognises Australia’s first healers and scientists, the Aboriginal and Torres Strait Islander peoples. We acknowledge the Whadjuk people of the Noongar nation, the Traditional Custodians of the lands where we live and work, and pay respects to their elders past and present.